OptimizeRx to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022
OptimizeRx management to participate in upcoming LifeSci Partners Corporate Access Event 2022
OptimizeRx’s Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360
The solution uses the Company’s AI-driven Therapy Initiation and Persistence Platform to deliver tailored engagement leveraging real-world evidence insights in real-time.
2022 forecast: From copywriting to compliance, expect pharma marketers to find new ways to tap AI's potential
When the pandemic hit in 2020 and reps couldn’t see doctors face-to-face, many more pharma marketers turned to AI to help their brands get noticed by the right doctors at the ideal moment.
OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes
OptimizeRx CEO issues open letter to shareholders detailing the completion of internal management changes.
OptimizeRx Survey Addresses Treatment Selection, Discontinuation and Switching in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer – an Indication with Limited Patient Population
Oncologists share the factors that influence treatment selection and persistence in ALK+ lung cancer, revealing how pharma manufacturers can better support patients and physicians
PM360 2021 Innovative Product Evidence-based Physician Engagement Solution from OptimizeRx
PM360 Presents the 2021 Innovators. OptimizeRx's RWE solution recognized as one of the most innovative products for life sciences.
